Transjugular intrahepatic portosystemic stent-shunt in the management of portal hypertension

TLDR

The guidelines do not address management of underlying liver disease, pediatric TIPSS, or complex technical aspects. They are intended for clinicians considering referring a patient for a TIPSS. The guidelines were developed by a multidisciplinary BSG Liver Section group, graded with GRADE, and organized into sections on indications, patient selection, procedural details, complications, and research agenda. These new guidelines were commissioned by the CSSC of the BSG Liver Section and produced in collaboration with the BSIR and BASL.

Abstract

These guidelines on transjugular intrahepatic portosystemic stent-shunt (TIPSS) in the management of portal hypertension have been commissioned by the Clinical Services and Standards Committee (CSSC) of the British Society of Gastroenterology (BSG) under the auspices of the Liver Section of the BSG. The guidelines are new and have been produced in collaboration with the British Society of Interventional Radiology (BSIR) and British Association of the Study of the Liver (BASL). The guidelines development group comprises elected members of the BSG Liver Section, representation from BASL, a nursing representative and two patient representatives. The quality of evidence and grading of recommendations was appraised using the GRADE system. These guidelines are aimed at healthcare professionals considering referring a patient for a TIPSS. They comprise the following subheadings: indications; patient selection; procedural details; complications; and research agenda. They are not designed to address: the management of the underlying liver disease; the role of TIPSS in children; or complex technical and procedural aspects of TIPSS.